 | • レポートコード：QAF27832 • 出版社/出版日：QYResearch / 2021年4月7日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の百日咳ワクチン市場について種類別（全細胞ワクチン、無細胞ワクチン）、用途別（子供、大人）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・百日咳ワクチン市場の概要 ・世界の主要地域別百日咳ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の百日咳ワクチン市場規模2016-2021：種類別（全細胞ワクチン、無細胞ワクチン） ・世界の百日咳ワクチン市場予測2012-2027：種類別（全細胞ワクチン、無細胞ワクチン） ・世界の百日咳ワクチン市場規模2016-2021：用途別（子供、大人） ・世界の百日咳ワクチン市場予測2012-2027：用途別（子供、大人） ・百日咳ワクチンのアメリカ市場規模と予測2016-2021 ・百日咳ワクチンのヨーロッパ市場規模と予測2016-2021 ・百日咳ワクチンの中国市場規模と予測2016-2021 ・百日咳ワクチンの日本市場規模と予測2016-2021 ・百日咳ワクチンの東南アジア市場規模と予測2016-2021 ・百日咳ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、Wuhan Institute of Biological Products、Walvax Biotechnology、Minhai Biotechnology） ・百日咳ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・百日咳ワクチンの市場動向・機会・課題 ・調査の結論 |
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.
The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
Market Analysis and Insights: Global Pertussis Vaccine Market
The global Pertussis Vaccine market was valued at US$ 5047.1 in 2020 and will reach US$ 5518.8 million by the end of 2027, growing at a CAGR of 1.5% during 2022-2027.
Global Pertussis Vaccine Scope and Market Size
The global Pertussis Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Whole-cell vaccines
Acellular vaccines
Segment by Application
Children
Adults
The Pertussis Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pertussis Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
1 Pertussis Vaccine Market Overview
1.1 Pertussis Vaccine Product Scope
1.2 Pertussis Vaccine Segment by Type
1.2.1 Global Pertussis Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Whole-cell vaccines
1.2.3 Acellular vaccines
1.3 Pertussis Vaccine Segment by Application
1.3.1 Global Pertussis Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Children
1.3.3 Adults
1.4 Pertussis Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pertussis Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pertussis Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pertussis Vaccine Price Trends (2016-2027)
2 Pertussis Vaccine Estimates and Forecasts by Region
2.1 Global Pertussis Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pertussis Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pertussis Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Pertussis Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Pertussis Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pertussis Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pertussis Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.3 China Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.6 India Pertussis Vaccine Estimates and Projections (2016-2027)
3 Global Pertussis Vaccine Competition Landscape by Players
3.1 Global Top Pertussis Vaccine Players by Sales (2016-2021)
3.2 Global Top Pertussis Vaccine Players by Revenue (2016-2021)
3.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2020)
3.4 Global Pertussis Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Pertussis Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pertussis Vaccine Market Size by Type
4.1 Global Pertussis Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Pertussis Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Pertussis Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Pertussis Vaccine Price by Type (2016-2021)
4.2 Global Pertussis Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pertussis Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Pertussis Vaccine Price Forecast by Type (2022-2027)
5 Global Pertussis Vaccine Market Size by Application
5.1 Global Pertussis Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Pertussis Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Pertussis Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Pertussis Vaccine Price by Application (2016-2021)
5.2 Global Pertussis Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pertussis Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Pertussis Vaccine Price Forecast by Application (2022-2027)
6 North America Pertussis Vaccine Market Facts & Figures
6.1 North America Pertussis Vaccine Sales by Company
6.1.1 North America Pertussis Vaccine Sales by Company (2016-2021)
6.1.2 North America Pertussis Vaccine Revenue by Company (2016-2021)
6.2 North America Pertussis Vaccine Sales Breakdown by Type
6.2.1 North America Pertussis Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Pertussis Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Pertussis Vaccine Sales Breakdown by Application
6.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Pertussis Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Pertussis Vaccine Market Facts & Figures
7.1 Europe Pertussis Vaccine Sales by Company
7.1.1 Europe Pertussis Vaccine Sales by Company (2016-2021)
7.1.2 Europe Pertussis Vaccine Revenue by Company (2016-2021)
7.2 Europe Pertussis Vaccine Sales Breakdown by Type
7.2.1 Europe Pertussis Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pertussis Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Pertussis Vaccine Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Pertussis Vaccine Market Facts & Figures
8.1 China Pertussis Vaccine Sales by Company
8.1.1 China Pertussis Vaccine Sales by Company (2016-2021)
8.1.2 China Pertussis Vaccine Revenue by Company (2016-2021)
8.2 China Pertussis Vaccine Sales Breakdown by Type
8.2.1 China Pertussis Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Pertussis Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Pertussis Vaccine Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Pertussis Vaccine Market Facts & Figures
9.1 Japan Pertussis Vaccine Sales by Company
9.1.1 Japan Pertussis Vaccine Sales by Company (2016-2021)
9.1.2 Japan Pertussis Vaccine Revenue by Company (2016-2021)
9.2 Japan Pertussis Vaccine Sales Breakdown by Type
9.2.1 Japan Pertussis Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pertussis Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Pertussis Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Pertussis Vaccine Market Facts & Figures
10.1 Southeast Asia Pertussis Vaccine Sales by Company
10.1.1 Southeast Asia Pertussis Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Pertussis Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Pertussis Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Pertussis Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pertussis Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pertussis Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Pertussis Vaccine Market Facts & Figures
11.1 India Pertussis Vaccine Sales by Company
11.1.1 India Pertussis Vaccine Sales by Company (2016-2021)
11.1.2 India Pertussis Vaccine Revenue by Company (2016-2021)
11.2 India Pertussis Vaccine Sales Breakdown by Type
11.2.1 India Pertussis Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Pertussis Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Pertussis Vaccine Sales Breakdown by Application
11.3.1 India Pertussis Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Pertussis Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Pertussis Vaccine Business
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Corporation Information
12.1.2 Sanofi Pasteur Business Overview
12.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Pertussis Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Mitsubishi Tanabe Pharma
12.3.1 Mitsubishi Tanabe Pharma Corporation Information
12.3.2 Mitsubishi Tanabe Pharma Business Overview
12.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
12.3.5 Mitsubishi Tanabe Pharma Recent Development
12.4 Wuhan Institute of Biological Products
12.4.1 Wuhan Institute of Biological Products Corporation Information
12.4.2 Wuhan Institute of Biological Products Business Overview
12.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
12.4.5 Wuhan Institute of Biological Products Recent Development
12.5 Walvax Biotechnology
12.5.1 Walvax Biotechnology Corporation Information
12.5.2 Walvax Biotechnology Business Overview
12.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Walvax Biotechnology Pertussis Vaccine Products Offered
12.5.5 Walvax Biotechnology Recent Development
12.6 Minhai Biotechnology
12.6.1 Minhai Biotechnology Corporation Information
12.6.2 Minhai Biotechnology Business Overview
12.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Minhai Biotechnology Pertussis Vaccine Products Offered
12.6.5 Minhai Biotechnology Recent Development
…
13 Pertussis Vaccine Manufacturing Cost Analysis
13.1 Pertussis Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pertussis Vaccine
13.4 Pertussis Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pertussis Vaccine Distributors List
14.3 Pertussis Vaccine Customers
15 Market Dynamics
15.1 Pertussis Vaccine Market Trends
15.2 Pertussis Vaccine Drivers
15.3 Pertussis Vaccine Market Challenges
15.4 Pertussis Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pertussis Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Pertussis Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Pertussis Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Pertussis Vaccine Sales (K Doses) by Region (2016-2021)
Table 5. Global Pertussis Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Pertussis Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Pertussis Vaccine Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Pertussis Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Pertussis Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Pertussis Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Pertussis Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Pertussis Vaccine Sales Share by Company (2016-2021)
Table 14. Global Pertussis Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Pertussis Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertussis Vaccine as of 2020)
Table 17. Global Pertussis Vaccine Average Price (USD/Doses) of Key Company (2016-2021)
Table 18. Manufacturers Pertussis Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Pertussis Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Pertussis Vaccine Sales (K Doses) by Type (2016-2021)
Table 22. Global Pertussis Vaccine Sales Share by Type (2016-2021)
Table 23. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Pertussis Vaccine Price (USD/Doses) by Type (2016-2021)
Table 25. Global Pertussis Vaccine Sales Share by Type (2022-2027)
Table 26. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Pertussis Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Pertussis Vaccine Price (USD/Doses) by Type (2022-2027)
Table 29. Global Pertussis Vaccine Sales (K Doses) by Application (2016-2021)
Table 30. Global Pertussis Vaccine Sales Share by Application (2016-2021)
Table 31. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Pertussis Vaccine Price (USD/Doses) by Application (2016-2021)
Table 33. Global Pertussis Vaccine Sales (K Doses) by Application (2022-2027)
Table 34. Global Pertussis Vaccine Sales Share by Application (2022-2027)
Table 35. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Pertussis Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Pertussis Vaccine Price (USD/Doses) by Application (2022-2027)
Table 38. North America Pertussis Vaccine Sales (K Doses) by Company (2016-2021)
Table 39. North America Pertussis Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Pertussis Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Pertussis Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Pertussis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 43. North America Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Pertussis Vaccine Sales by Type (2022-2027) & (K Doses)
Table 45. North America Pertussis Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Pertussis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 47. North America Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Pertussis Vaccine Sales by Application (2022-2027) & (K Doses)
Table 49. North America Pertussis Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Pertussis Vaccine Sales (K Doses) by Company (2016-2021)
Table 51. Europe Pertussis Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Pertussis Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Pertussis Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Pertussis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Pertussis Vaccine Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Pertussis Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Pertussis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Pertussis Vaccine Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Pertussis Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Pertussis Vaccine Sales (K Doses) by Company (2016-2021)
Table 63. China Pertussis Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Pertussis Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Pertussis Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Pertussis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 67. China Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Pertussis Vaccine Sales by Type (2022-2027) & (K Doses)
Table 69. China Pertussis Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Pertussis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 71. China Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Pertussis Vaccine Sales by Application (2022-2027) & (K Doses)
Table 73. China Pertussis Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Pertussis Vaccine Sales (K Doses) by Company (2016-2021)
Table 75. Japan Pertussis Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Pertussis Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Pertussis Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Pertussis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Pertussis Vaccine Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Pertussis Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Pertussis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Pertussis Vaccine Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Pertussis Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Pertussis Vaccine Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Pertussis Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Pertussis Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Pertussis Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Pertussis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Pertussis Vaccine Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Pertussis Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Pertussis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Pertussis Vaccine Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Pertussis Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Pertussis Vaccine Sales (K Doses) by Company (2016-2021)
Table 99. India Pertussis Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Pertussis Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Pertussis Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Pertussis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 103. India Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Pertussis Vaccine Sales by Type (2022-2027) & (K Doses)
Table 105. India Pertussis Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Pertussis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 107. India Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Pertussis Vaccine Sales by Application (2022-2027) & (K Doses)
Table 109. India Pertussis Vaccine Sales Market Share by Application (2022-2027)
Table 110. Sanofi Pasteur Corporation Information
Table 111. Sanofi Pasteur Description and Business Overview
Table 112. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 113. Sanofi Pasteur Pertussis Vaccine Product
Table 114. Sanofi Pasteur Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 118. GSK Pertussis Vaccine Product
Table 119. GSK Recent Development
Table 120. Mitsubishi Tanabe Pharma Corporation Information
Table 121. Mitsubishi Tanabe Pharma Description and Business Overview
Table 122. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 123. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 124. Mitsubishi Tanabe Pharma Recent Development
Table 125. Wuhan Institute of Biological Products Corporation Information
Table 126. Wuhan Institute of Biological Products Description and Business Overview
Table 127. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 128. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 129. Wuhan Institute of Biological Products Recent Development
Table 130. Walvax Biotechnology Corporation Information
Table 131. Walvax Biotechnology Description and Business Overview
Table 132. Walvax Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 133. Walvax Biotechnology Pertussis Vaccine Product
Table 134. Walvax Biotechnology Recent Development
Table 135. Minhai Biotechnology Corporation Information
Table 136. Minhai Biotechnology Description and Business Overview
Table 137. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 138. Minhai Biotechnology Pertussis Vaccine Product
Table 139. Minhai Biotechnology Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Pertussis Vaccine Distributors List
Table 143. Pertussis Vaccine Customers List
Table 144. Pertussis Vaccine Market Trends
Table 145. Pertussis Vaccine Market Drivers
Table 146. Pertussis Vaccine Market Challenges
Table 147. Pertussis Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pertussis Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Children Examples
Figure 7. Adults Examples
Figure 8. Global Pertussis Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Pertussis Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Pertussis Vaccine Sales (K Doses) Growth Rate (2016-2027)
Figure 11. Global Pertussis Vaccine Price Trends Growth Rate (2016-2027) (USD/Doses)
Figure 12. Global Pertussis Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Pertussis Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Pertussis Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Pertussis Vaccine Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Europe Pertussis Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Pertussis Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Pertussis Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Pertussis Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Pertussis Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Pertussis Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Pertussis Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Pertussis Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Pertussis Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Pertussis Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Pertussis Vaccine Players Market Share by Revenue in Pertussis Vaccine: 2016 & 2020
Figure 27. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Pertussis Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Pertussis Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Pertussis Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Pertussis Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Pertussis Vaccine Sales Market Share by Type in 2020
Figure 33. North America Pertussis Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Pertussis Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Pertussis Vaccine Sales Market Share by Application in 2020
Figure 36. China Pertussis Vaccine Sales Market Share by Type in 2020
Figure 37. China Pertussis Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Pertussis Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Pertussis Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Pertussis Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Pertussis Vaccine Sales Market Share by Application in 2020
Figure 42. India Pertussis Vaccine Sales Market Share by Type in 2020
Figure 43. India Pertussis Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Pertussis Vaccine
Figure 46. Manufacturing Process Analysis of Pertussis Vaccine
Figure 47. Pertussis Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
人用ワクチンのグローバル市場2021 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …- インフルエンザワクチンのグローバル市場2021 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- 世界の水産養殖用ワクチン市場規模・現状・予測（2021年-2027年） It is a biological preparation that improves immunity to a particular disease work on aquaculture. Market Analysis and Insights: Global Aquaculture Vaccine Market The global Aquaculture Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% du…
- インフルエンザ用ワクチンのグローバル市場2021 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- 魚類ワクチンのグローバル市場2021 Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed an…